# Editorial: Advances in new combinational therapies for treatment of MDR pathogens

**Authors:** Sanjit Kumar, Biswajit Mishra, Anshul Chaudhary, Sanket Kaushik

PMC · DOI: 10.3389/fcimb.2025.1709379 · Frontiers in Cellular and Infection Microbiology · 2025-11-04

## Full-text entities

- **Genes:** HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, SFTPA1 (surfactant protein A1) [NCBI Gene 653509] {aka COLEC4, ILD1, PSP-A, PSPA, SFTP1, SFTPA1B}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, TLR3 (toll like receptor 3) [NCBI Gene 7098] {aka CD283, IIAE2, IMD83}
- **Diseases:** wound infections (MESH:D014946), infectious diseases (MESH:D003141), splenic damage (MESH:D013158), edema (MESH:D004487), pulmonary lesion (MESH:D008171), irritation (MESH:D001523), inflammatory (MESH:D007249)
- **Chemicals:** amikacin (MESH:D000583), SabiWhite (MESH:C096277), caryophyllene (MESH:C024714), AgNP (-), reactive oxygen species (MESH:D017382), glucose (MESH:D005947), beta-lactam (MESH:D047090), ciprofloxacin (MESH:D002939), oxygen (MESH:D010100), erythromycin (MESH:D004917), amoxicillin (MESH:D000658), silver (MESH:D012834), Essential oils (MESH:D009822), alpha-pinene (MESH:C005451), Diclofenac (MESH:D004008)
- **Species:** Escherichia fergusonii (species) [taxon 564], Pseudomonas aeruginosa (species) [taxon 287], Mus musculus (house mouse, species) [taxon 10090], Glycine max (soybean, species) [taxon 3847], hepatitis C virus [taxon 11103], Escherichia coli (E. coli, species) [taxon 562], Allium sativum (garlic, species) [taxon 4682], Streptomyces kanamyceticus (species) [taxon 1967]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12623395/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12623395/full.md

---
Source: https://tomesphere.com/paper/PMC12623395